Financhill
Back

AC Immune SA Quote, Financials, Valuation and Earnings

AC Immune SA Price Quote

$2.66
-0.02 (-1.48%)
(Updated: December 21, 2024 at 5:13 AM ET)

AC Immune SA Key Stats

Sell
22
AC Immune SA (ACIU) is a Sell

Day range:
$2.63 - $2.77
52-week range:
$2.25 - $5.14
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
1.71%

Volume:
236K
Avg. volume:
150.5K
1-year change:
-33.83%
Market cap:
$265.2M
Revenue:
$16.5M
EPS:
$-0.46

How Much Does AC Immune SA Make?

Data Unavailable

Is AC Immune SA Growing As A Company?

Data Unavailable

AC Immune SA Stock Price Performance

  • Did AC Immune SA Stock Go Up Last Month?
    AC Immune SA share price went down by -17.28% last month
  • Did ACIU's Share Price Rise Over The Last Year?
    ACIU share price fell by -33.83% over the past 1 year

What Is AC Immune SA 52-Week High & Low?

AC Immune SA Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy AC Immune SA?

Data Unavailable

Is AC Immune SA Cash Flow Positive?

Data Unavailable

AC Immune SA Return On Invested Capital

Data Unavailable

AC Immune SA Earnings Date & Stock Price

  • What Is AC Immune SA's Stock Price Today?
    A single share of ACIU can be purchased today for 2.68
  • What Is AC Immune SA’s Stock Symbol?
    AC Immune SA trades on the nasdaq under the ticker symbol: ACIU
  • When Is AC Immune SA’s Next Earnings Date?
    The next quarterly earnings date for AC Immune SA is scheduled on February 6, 2025
  • When Is ACIU's next ex-dividend date?
    AC Immune SA's next ex-dividend date is December 22, 2024
  • How To Buy AC Immune SA Stock?
    You can buy AC Immune SA shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

AC Immune SA Competitors

  • Who Are AC Immune SA's Competitors?
    Below is a list of companies who compete with AC Immune SA or are related in some way:
    • Addex Therapeutics Ltd (ADXN)
    • CRISPR Therapeutics AG (CRSP)
    • MoonLake Immunotherapeutics (MLTX)
    • Molecular Partners AG (MOLN)
    • NLS Pharmaceutics Ltd (NLSP)

AC Immune SA Dividend Yield

Data Unavailable

AC Immune SA Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 125.81%
Revenue: 0% 250.11%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 0.00
Downside from Last Price: -100%

Major Shareholders

Data Unavailable